“Establishment and Characterization of Primary Human Ovarian Cancer Stem Cell Line (CD44+ve)”, J. Can. Res. Updates, vol. 5, no. 2, pp.  59–66, Mar. 2016, doi: 10.6000/1929-2279.2016.05.02.3.